Perez-Alvarez Idanis M, Zolper Elizabeth G, Schwitzer Jonathan, Fan Kenneth L, Del Corral Gabriel A
Georgetown University School of Medicine; Washington, District of Columbia, USA.
Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital; Washington, District of Columbia, USA.
World J Plast Surg. 2021 May;10(2):14-24. doi: 10.29252/wjps.10.2.14.
BACKGROUND: Chest masculinization is aimed at aligning physical appearance of female-to-male (FtM) transgender patients to their identifying gender. Despite limited evidence, obese FtM patients have historically been denied this procedure due to concerns of complications. We reviewed chest masculinization in the high body mass index (BMI) population to analyze the outcomes. METHODS: A Medstar system single surgeon retrospective case review was performed of all FtM patients who underwent chest masculinization from Jan 2018 to Dec 2019 with a BMI greater than 30 kg/m. Primary outcomes were mastectomy-site complications. RESULTS: Twenty-seven obese FtM patients who underwent bilateral chest masculinization were identified. Mean BMI was 39.2 kg/m (SD 5.2). Preoperatively, the majority of patients had a cup size of D or larger (77.3%) and grade 3 ptosis (80.0%). Overall rate of complications was 31.5% at median follow-up of 2.1 months. Individual complications included: partial nipple graft loss 18.5%, total nipple graft loss 5.6%, seroma 3.7%, hematoma 3.7%, infection 2.9%. No complications necessitated return to the operating room. However, the majority of patients (77.8%) were completely satisfied with their aesthetic outcome. CONCLUSION: Mastectomy can be safely performed for chest masculinization in obese FtM patients. The rate of acute complications is comparable to that of non-obese patients despite a mean BMI near 40 kg/m in this case series. A safe procedure with high satisfaction, obese FtM patients should not be excluded from the increased quality of life and dysphoria reduction chest wall masculinization offers.
背景:胸部男性化旨在使女性变男性(FtM)跨性别患者的外貌与其认同的性别相符。尽管证据有限,但由于担心并发症,肥胖的FtM患者历来被拒绝接受该手术。我们回顾了高体重指数(BMI)人群的胸部男性化手术,以分析其结果。 方法:对2018年1月至2019年12月期间接受胸部男性化手术且BMI大于30kg/m²的所有FtM患者进行了Medstar系统单外科医生回顾性病例分析。主要结局是乳房切除部位的并发症。 结果:确定了27例接受双侧胸部男性化手术的肥胖FtM患者。平均BMI为39.2kg/m²(标准差5.2)。术前,大多数患者的罩杯尺寸为D或更大(77.3%),且有3级下垂(80.0%)。在中位随访2.1个月时,总体并发症发生率为31.5%。个体并发症包括:部分乳头移植丢失18.5%,乳头移植完全丢失5.6%,血清肿3.7%,血肿3.7%,感染2.9%。没有并发症需要返回手术室。然而,大多数患者(77.8%)对其美学效果完全满意。 结论:肥胖的FtM患者可以安全地进行乳房切除术以实现胸部男性化。尽管本病例系列的平均BMI接近40kg/m²,但急性并发症发生率与非肥胖患者相当。这是一种安全且满意度高的手术,肥胖的FtM患者不应被排除在胸壁男性化所带来的生活质量提高和烦躁不安减轻之外。
Aesthet Surg J. 2020-2-17
Plast Reconstr Surg Glob Open. 2021-3-15
Ann Transl Med. 2021-4
Indian J Plast Surg. 2024-2-6
J Plast Reconstr Aesthet Surg. 2024-8
Eur J Plast Surg. 2023-1-5
Int J Transgend Health. 2025-7-16
Transgend Health. 2025-6-5
Aesthetic Plast Surg. 2025-5-12
J Cutan Aesthet Surg. 2025
Int J Transgend Health. 2024-2-5
Plast Reconstr Surg Glob Open. 2024-12-6
Plast Reconstr Surg. 2025-6-1
Aesthetic Plast Surg. 2024-11
Plast Reconstr Surg. 2019-4
Plast Reconstr Surg. 2018-12
Plast Reconstr Surg. 2018-4
Ann Plast Surg. 2018-6
Ann Plast Surg. 2018-1
Ann Plast Surg. 2017-9
Plast Reconstr Surg. 2017-4